We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Full Fed. Circ. Limits On-Sale Bar’s Reach In Angiomax Case

Law360, New York (July 11, 2016, 11:37 AM EDT) -- The full Federal Circuit ruled Monday that the on-sale bar invalidating a patent is triggered only by a transaction that “bears the general hallmarks of a sale,” holding that The Medicines...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.